We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avingtrans Plc | LSE:AVG | London | Ordinary Share | GB0009188797 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 405.00 | 400.00 | 410.00 | 405.00 | 405.00 | 405.00 | 13,020 | 08:00:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Engineering Services | 116.95M | 5.19M | 0.1579 | 25.65 | 133.23M |
TIDMAVG
RNS Number : 2437J
Avingtrans PLC
07 September 2016
07 September 2016
Avingtrans Plc
("Avingtrans" or the "Company" or the "Group")
Exercise of Share Options
Avingtrans (AIM:AVG), a manufacturer of critical components and associated services to the global aerospace, energy and medical sectors announces that on 7 September 2016 the Company issued 8,167 ordinary shares of 5 pence each ("Ordinary Shares") following the exercise of options under the Company's CSOP share option scheme.
Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and it is expected that admission will take place on 13 September 2016. Upon Admission, the shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.
After admission of these new shares, the Company's total issued share capital is 27,998,569 Ordinary Shares. Avingtrans does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in Avingtrans is 27,998,569.
The above figure 27,998,569 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Avingtrans under the FSA's Disclosure and Transparency Rules.
Enquiries:
Avingtrans plc Steve McQuillan, CEO Stephen King, CFO 0115 949 9020 Numis Securities Limited Tom Ballard (Corporate Broking) Richard Thomas (Corporate Finance and Nominated Adviser) 020 7260 1000 Newgate (Financial PR) Adam Lloyd Ed Treadwell 020 7653 9850
About Avingtrans
Energy and medical, engaged in the design and manufacture of safety critical equipment for the energy, medical, science and research communities, including oil and gas extraction and processing equipment, nuclear process plant, machined and fabricated pressure and vacuum vessels and components. Also, design and manufacture of fabricated poles and cabinets for roadside safety cameras and rail track signalling.
The strategy of the group, is to "buy and build" in regulated engineering niche markets, where we can see potential consolidation opportunities, which can lead to significantly increased shareholder value over the medium to long term
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKNXEASKEFF
(END) Dow Jones Newswires
September 07, 2016 12:30 ET (16:30 GMT)
1 Year Avingtrans Chart |
1 Month Avingtrans Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions